The Total Knee Arthroplasty Market, estimated at USD 10.61 Bn in 2025, is expected to exhibit a CAGR of 5% and reach USD 14.93 Bn by 2032.
The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.
Global total knee arthroplasty market is expected to witness significant growth over the forecast period, due to increasing road accidents. For instance, according to data presented by the National Highway highway Safety Administration in the U.S.,highway deaths increased by roughly 10.5% in 2021 as compared to 2020 in May 2022. It also stated that fatalities on urban roads were roughly 57.0% in March 2020, rising to 62.0% in March 2021, thus representing a nearly 5.0% rise over the previous year. Similarly, according to the data published by the World Health Organization (WHO), in June 2022, road traffic injuries are one of the main causes of death among young adults aged 5 to 29 years and children. It also stated that 93.0% of global fatalities occur primarily in middle and low-income
Global Total Knee Arthroplasty Market - Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China), in the last months of 2019, as "coronavirus disease 2019" or COVID-19. This virus spreads quickly, and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
Even when elective surgeries resumed, some patients chose to delay or avoid non-urgent procedures due to concerns about potential exposure to the virus in healthcare settings. This led to a reduction in the number of total knee arthroplasties performed during certain periods. Hospitals faced challenges in managing resources such as operating rooms, intensive care units, and healthcare personnel. The need to allocate resources to COVID-19 patients affected the availability of facilities and personnel for elective procedures like total knee arthroplasty. Accordign to an article published, by Journal of American Academy of Orthopaedic Surgeons, a digital journal covering orthopaedic medicine, in the U.S. in December 2022, there was a decrease of 31.4% in total knee arthroplasty surgeries performed in 2020 as compared with surgeries performed in 2019.
Global Total Knee Arthroplasty Market: Key Developments
On March 08, 2023, Stryker, a medical device company, announced Mako Total Knee 2.0, the latest chapter in the Mako SmartRobotics series, at the American Academy of Orthopaedic Surgeons 2023 Annual Meeting in Las Vegas. Mako Total Knee 2.0 is based on over 500,000 Mako Total Knee surgeries and is meant to give the same, trusted outcomes surgeons expect from Mako with a new, improved user experience.
On March 06, 2023, Smith+Nephew, a global medical technology company, announced a systemic literature review and meta-analysis of its VISIONAIRE Patient-Specific Instrumentation (PSI), demonstrating that its use improves alignment accuracy, efficiency in surgical procedures, and length of hospital stay when compared to conventional instrumentation.